Early RNA Life May Have Repaired Genomes, Shedding Light on Origins

In a groundbreaking study published in Nature Communications, researchers from the University of Notre Dame have engineered a novel ribozyme capable of selectively recognizing and repairing broken RNA strands. This discovery sheds new light on the RNA World hypothesis and offers promising applications in modern biotechnology.

The RNA World hypothesis posits that early life forms relied solely on RNA molecules for both genetic information storage and catalysis, predating the evolution of DNA and proteins. A critical question has long remained: how could fragile RNA genomes have survived damage in primordial environments without protein-based repair systems? The newly identified ribozyme addresses this by distinguishing between intact RNA strands terminating in hydroxyl groups and damaged strands bearing terminal phosphate groups.

Unlike modern DNA repair enzymes, this engineered ribozyme ligase specifically targets RNA molecules with a 3′ terminal phosphate at the break site, effectively “healing” them by catalyzing ligation. This activity suggests that ancient RNA-based life forms could have sustained their genetic information autonomously, without reliance on proteins. Such a mechanism would have been essential to maintaining the integrity of RNA genomes exposed to environmental stressors like heat or alkaline pH, which commonly cause strand cleavage.

The team employed in vitro evolution, an experimental approach simulating natural selection in the lab, to screen trillions of RNA sequences and isolate ribozymes with this unique function. While initially aiming to modify known ribozyme classes, serendipitous results led them to this novel ligase activity. “The existence of this ribozyme has fascinating implications for our understanding of life’s chemical origins,” remarked lead researcher Saurja DasGupta.

Beyond evolutionary insights, this ribozyme could revolutionize RNA analysis in biomedicine. Broken RNA fragments are prevalent in viral infections and certain cancers but are often undetected by current sequencing techniques because these methods fail to attach necessary chemical tags to damaged RNA ends. By selectively binding to terminal phosphate groups, the enzyme can isolate and prepare cleaved RNA strands for sequencing, potentially unveiling novel biomarkers of disease.

Currently, efforts are underway to enhance the enzyme’s efficiency and expand its specificity toward a broader array of RNA substrates. The dual relevance of this ribozyme—from primordial RNA repair to cutting-edge diagnostics—highlights the enduring value of understanding ancient molecular processes through modern biochemical innovation.

This unexpected discovery underscores the power of experimental evolution and the intricate chemistry at the heart of the origin of life. As research continues, the boundary between ancient molecular biology and contemporary biotechnology grows ever more blurred, promising exciting frontiers ahead.